| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/22/2004 | WO2003025121A3 Igf-binding protein-derived peptide or small molecule |
| 01/22/2004 | WO2003024996A3 Antibacterial macrocycles |
| 01/22/2004 | WO2003019195A3 Cellular immunity test with peptides fixed on a solid support |
| 01/22/2004 | WO2002099120A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/22/2004 | WO2002065986A3 Transporters comprising spaced arginine moieties |
| 01/22/2004 | US20040014964 Vitronectin receptor antagonist pharmaceuticals |
| 01/22/2004 | US20040014670 Inhibitors of angiotensin converting enzyme |
| 01/22/2004 | US20040014653 Oral diseases; skin disorders; aging resistance |
| 01/22/2004 | US20040014649 Antiallergens, vision defects, skin disorders, asthma therapy |
| 01/22/2004 | US20040014646 Antibiotics AW998A, AW998B, AW998C and AW998D |
| 01/22/2004 | US20040014638 Antiallergens, vision defects, skin disorders, asthma therapy |
| 01/22/2004 | US20040014602 Using antibiotic |
| 01/22/2004 | US20040014159 Methods and kits for transferases |
| 01/22/2004 | US20040014148 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein |
| 01/22/2004 | US20040014143 Classification, separation and detection of neuropeptides; diagnosis and treatment of nervous system disorders |
| 01/22/2004 | US20040014082 Highly homogeneous molecular markers for electrophoresis |
| 01/22/2004 | US20040013673 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria |
| 01/22/2004 | CA2800113A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 01/22/2004 | CA2491969A1 Method for identifying individual active entities from complex mixtures |
| 01/22/2004 | CA2489189A1 Bicyclic oligopeptides and their use as glucagon receptor antagonists |
| 01/22/2004 | CA2487378A1 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 01/21/2004 | EP1381683A2 Human fibroblast growth factor-related compositions |
| 01/21/2004 | EP1381627A2 Polypeptides derived from amyloid precursor peptide (app) and their uses |
| 01/21/2004 | EP1381397A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman |
| 01/21/2004 | EP0787009B1 Cancer inhibitory peptides |
| 01/21/2004 | EP0759772B1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 01/21/2004 | EP0667786B1 Retro-, inverso-, and retro-inverso synthetic peptide analogues |
| 01/21/2004 | CN1469754A Orally administered peptides to ameliorate a therosclerosis |
| 01/21/2004 | CN1135236C 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 01/20/2004 | US6680367 Light emitting compounds; probes; receptor binding assays |
| 01/20/2004 | US6680298 Administering polypeptide to increase serum levels; dietetics, hypoglycemic agents; cardiovascular, autoimmune, kidney, metabolic and nervous system disorder treatment |
| 01/20/2004 | US6680173 Diagnosis of tauopathies |
| 01/20/2004 | US6680058 Compositions and methods for contraception in or sterilization of mammals |
| 01/20/2004 | CA2090961C Specific binding agents |
| 01/15/2004 | WO2004005925A2 Diagnostics method |
| 01/15/2004 | WO2004005920A2 Method for enriching and tracking pathologic modified prions-proteins (prpsc) |
| 01/15/2004 | WO2004005529A2 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/15/2004 | WO2004005329A1 Plant peptide with antimicrobial activity |
| 01/15/2004 | WO2004005318A2 Peptides comprising aromatic d-amino acids and methods of use |
| 01/15/2004 | WO2003099868A3 Method for obtaining anti-idiotype antibodies |
| 01/15/2004 | WO2003092608A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/15/2004 | WO2003059933A3 Conformationally constrained c-backbone cyclic peptides |
| 01/15/2004 | WO2003046557A3 Hp biopolymer markers predictive of insulin resistance |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010116 Comprises peptide for treating cancer, nervous system, autoimmune and arthritic disorders; high throughput assay; epitope mapping; drug design |
| 01/15/2004 | US20040009922 A PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof |
| 01/15/2004 | US20040009910 Compositions and methods for treating infections using analogues of indolicidin |
| 01/15/2004 | US20040009905 Templates consist of cyclized peptides containing at least two residues in said cyclized peptide are joined by a naphthyl ring; and having bonded to it a linear peptide |
| 01/15/2004 | US20040009531 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 01/15/2004 | CA2491611A1 Peptides comprising aromatic d-amino acids and methods of use |
| 01/15/2004 | CA2491607A1 Plant peptide with antimicrobial activity |
| 01/15/2004 | CA2489151A1 Method for enriching and tracking pathologic modified prions-proteins (prpsc) |
| 01/14/2004 | EP1379655A2 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
| 01/14/2004 | EP1379650A2 Preferred segments of neural thread protein and methods of using the same |
| 01/14/2004 | EP1379644A2 Protein analysis by means of immobilized arrays of antigens or antibodies |
| 01/14/2004 | EP1379635A2 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 01/14/2004 | EP1379630A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
| 01/14/2004 | EP1379555A2 Modified interferon alpha with reduced immunogenicity |
| 01/14/2004 | EP1379547A2 Pro-drug and use thereof as a medicament |
| 01/14/2004 | EP1379546A2 Peptide for the diagnosis and therapy of alzheimer's disease |
| 01/14/2004 | EP1379283A2 Identification of target-specific folding sites in peptides and proteins |
| 01/14/2004 | EP1379265A2 Short bioactive peptides and methods for their use |
| 01/14/2004 | EP1379224A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/14/2004 | CN1468312A Chimeric gfp-aequorin as bioluminescent ca<++> reporters at the single cell level |
| 01/14/2004 | CN1467500A Immunoassay, reagent for immunoassay, and production method of the same |
| 01/14/2004 | CN1467220A Tripeptide analog, preparing method, medicine composition containing the same and uses |
| 01/14/2004 | CN1467219A Pentapeptide analog, preparation and uses thereof |
| 01/14/2004 | CN1134450C LH-RH peptide analogues, their uses and pharmaceutical compositions containing them |
| 01/13/2004 | US6677430 Polypeptides linked to labels used as detectors or kits for monitoring or analyzing biological receptors |
| 01/13/2004 | US6677429 Echinocandin derivatives, preparation method and application as anti-fungal agents |
| 01/13/2004 | US6677305 Insulin-like growth factor agonist molecules |
| 01/13/2004 | US6677116 Methods for treating cancer by modulating β-catenin mediated gene expression |
| 01/08/2004 | WO2004003561A1 Peptide rod amphiphiles and self-assembly of same |
| 01/08/2004 | WO2004003558A1 Nano-sized optical fluorescence labels and uses thereof |
| 01/08/2004 | WO2004003166A2 Antibodies and uses thereof |
| 01/08/2004 | WO2004003008A2 Peptides for inducing apoptosis in tumor cells |
| 01/08/2004 | WO2004003007A1 Non-t cell binding peptides and their uses |
| 01/08/2004 | WO2004003005A2 Sh2 domain binding inhibitors |
| 01/08/2004 | WO2004002510A1 Novel use of lipopeptide preparations |
| 01/08/2004 | WO2004002509A2 Use of casein peptides for treating hypertension |
| 01/08/2004 | WO2004002418A2 Compositions and methods comprising protein activated receptor antagonists |
| 01/08/2004 | WO2003093302A3 Process for the synthesis of peptides amides by side-chain attachement to a solid phase |
| 01/08/2004 | WO2003093301A3 Process for the synthesis of peptides |
| 01/08/2004 | WO2003047618A3 Immunotherapeutic methods and systems |
| 01/08/2004 | WO2003020205A3 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy |
| 01/08/2004 | WO2002103016B1 Human tachykinin-related splice variants and compositions thereof |
| 01/08/2004 | WO2002092623A8 INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF |
| 01/08/2004 | WO2002083065A3 Peptide antiangiogenic drugs |
| 01/08/2004 | WO2002072780A3 Igf antagonist peptides |
| 01/08/2004 | WO2002050250A3 Signal-1/signal-2 bifunctional peptide inhibitors |
| 01/08/2004 | US20040006203 Method for sequential support-bound synthesis of conjugated oligomeric compounds |
| 01/08/2004 | US20040006049 For therapy of prostatitis, benign prostate hyperplasia or prostate cancer |
| 01/08/2004 | US20040006022 For therapy of autoimmune or an inflammatory disease |
| 01/08/2004 | US20040006013 Linear and cyclic peptide and pseudopeptide compounds useful as analgesics, pharmaceutical compositions comprising such compounds, the use of the compounds and the compositions in the treatment of pain, and commercial packages containing such |
| 01/08/2004 | US20040006011 Peptidomimetic modulators of cell adhesion |
| 01/08/2004 | US20040006003 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 01/08/2004 | US20040005638 Determining concentration of target antibodies in mixtures; food analysis; disease diagnosis |
| 01/08/2004 | US20040005604 Comprises nucleotide sequences coding enzymatic polypeptide for degumming oil and food processing; antisense therapy |
| 01/08/2004 | US20040005307 Modulators of amyloid aggregation |
| 01/08/2004 | US20040005276 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |